Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
Clinical trial NCT04430192 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04430192
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-06
- Primary completion
- 2022-12-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.